{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:00:45Z","timestamp":1788778845190,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI119185"],"award-info":[{"award-number":["R01AI119185"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI132323"],"award-info":[{"award-number":["R01AI132323"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.xphs.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T10:59:02Z","timestamp":1599908342000},"page":"3716-3727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Preservation of Quaternary Structure in Thermostable, Lyophilized Filovirus Glycoprotein Vaccines: A Search for Stability-Indicating Assays"],"prefix":"10.1016","volume":"109","author":[{"given":"Kendall B.","family":"Preston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor R.","family":"Monticello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri Ann S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreola","family":"Donini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel T.","family":"Lehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore W.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2020.09.011_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3201\/eid1102.040533","article-title":"Wild animal mortality monitoring and human ebola outbreaks, Gabon and Republic of Congo, 2001-2003","volume":"11","author":"Rouquet","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.xphs.2020.09.011_bib5","series-title":"Opportunities and Challenges of Developing Thermostable Vaccines Opportunities and Challenges of Developing Thermostable Vaccines","first-page":"547","author":"Chen","year":"2014"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.011_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jps.10296","article-title":"Thermal stability of vaccines","volume":"92","author":"Brandau","year":"2003","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.09.011_bib7","series-title":"Summary of Stability Data for Licensed Vaccines","year":"2012"},{"key":"10.1016\/j.xphs.2020.09.011_bib8","series-title":"Vaccine Storage Chart","year":"2019"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.011_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.011_bib11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/infdis\/jiv532","article-title":"Stability of a vesicular stomatitis virus-vectored ebola vaccine","volume":"213","author":"Arnemo","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.xphs.2020.09.011_bib12","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/jps.21622","article-title":"Impact of sucrose level on storage stability of proteins in freeze-dried solids: II. Correlation of aggregation rate with protein structure and molecular mobility","volume":"98","author":"Wang","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"2019","key":"10.1016\/j.xphs.2020.09.011_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejpb.2019.01.019","article-title":"Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide","volume":"136","author":"Chisholm","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2020.09.011_bib14","series-title":"Development and Manufacture of Protein Pharmaceuticals","author":"Nail","year":"2002"},{"issue":"9","key":"10.1016\/j.xphs.2020.09.011_bib15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s13361-017-1739-3","article-title":"Addressing a common misconception: ammonium acetate as neutral pH \u201cbuffer\u201d for native electrospray mass spectrometry","volume":"28","author":"Konermann","year":"2017","journal-title":"J\u00a0Am Soc Mass Spectrom"},{"issue":"22","key":"10.1016\/j.xphs.2020.09.011_bib16","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2017.01.068","article-title":"Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice","volume":"36","author":"Lehrer","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2020.09.011_bib17","volume":"vol. 390","author":"Joseph","year":"2006"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.011_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr Purif"},{"issue":"SUPPL. 2","key":"10.1016\/j.xphs.2020.09.011_bib19","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.vaccine.2005.01.133","article-title":"Sucrose fatty acid sulphate esters as novel vaccine adjuvant","volume":"24","author":"Hilgers","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.011_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphere.00576-17","article-title":"Recombinant Zika virus subunits are immunogenic and efficacious in mice","volume":"3","author":"To","year":"2018","journal-title":"mSphere"},{"issue":"7","key":"10.1016\/j.xphs.2020.09.011_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0007614","article-title":"Serological evidence of Ebola virus exposure in dogs from affected communities in Liberia: a preliminary report","volume":"13","author":"Haun","year":"2019","journal-title":"PLoS Neglected Trop Dis"},{"issue":"7201","key":"10.1016\/j.xphs.2020.09.011_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2020.09.011_bib23","series-title":"Structure and Function of Intrinsically Disordered Proteins","author":"Tompa","year":"2010"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.011_bib24","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.011_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","article-title":"How to study proteins by circular dichroism","volume":"1751","author":"Kelly","year":"2005","journal-title":"Biochim Biophys Acta Protein Proteonomics"},{"issue":"9","key":"10.1016\/j.xphs.2020.09.011_bib26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1023\/A:1025771421906","article-title":"Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation","volume":"20","author":"Chi","year":"2003","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.xphs.2020.09.011_bib27","series-title":"Rational Design of Stable Protein Formulations: Theory and Practice","first-page":"159","article-title":"Surfactant-protein interactions","author":"Randolph","year":"2002"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:31:00Z","timestamp":1758360660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920305098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0022354920305098"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.011","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preservation of Quaternary Structure in Thermostable, Lyophilized Filovirus Glycoprotein Vaccines: A Search for Stability-Indicating Assays","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}